ArticleClinical hypertension2021

Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO).

Il Suk Sohn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.